Four distinct trajectories of tau deposition identified in Alzheimer's disease.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
05 2021
Historique:
received: 20 08 2020
accepted: 04 03 2021
pubmed: 1 5 2021
medline: 24 6 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

Alzheimer's disease (AD) is characterized by the spread of tau pathology throughout the cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, although recent work has demonstrated substantial variability in the population with AD. Using tau-positron emission tomography scans from 1,612 individuals, we identified 4 distinct spatiotemporal trajectories of tau pathology, ranging in prevalence from 18 to 33%. We replicated previously described limbic-predominant and medial temporal lobe-sparing patterns, while also discovering posterior and lateral temporal patterns resembling atypical clinical variants of AD. These 'subtypes' were stable during longitudinal follow-up and were replicated in a separate sample using a different radiotracer. The subtypes presented with distinct demographic and cognitive profiles and differing longitudinal outcomes. Additionally, network diffusion models implied that pathology originates and spreads through distinct corticolimbic networks in the different subtypes. Together, our results suggest that variation in tau pathology is common and systematic, perhaps warranting a re-examination of the notion of 'typical AD' and a revisiting of tau pathological staging.

Identifiants

pubmed: 33927414
doi: 10.1038/s41591-021-01309-6
pii: 10.1038/s41591-021-01309-6
pmc: PMC8686688
mid: NIHMS1760467
doi:

Substances chimiques

Carbolines 0
Radiopharmaceuticals 0
tau Proteins 0
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole J09QS3Z3WB

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

871-881

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : K99 AG065501
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG045611
Pays : United States
Organisme : Medical Research Council
ID : MR/S03546X/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : T32 MH019112
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : Medical Research Council
ID : MR/T027800/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : CIHR
Pays : Canada

Investigateurs

Michael Weiner (M)
Paul Aisen (P)
Ronald Petersen (R)
Clifford R Jack (CR)
William Jagust (W)
John Q Trojanowki (JQ)
Arthur W Toga (AW)
Laurel Beckett (L)
Robert C Green (RC)
Andrew J Saykin (AJ)
John Morris (J)
Leslie M Shaw (LM)
Enchi Liu (E)
Tom Montine (T)
Ronald G Thomas (RG)
Michael Donohue (M)
Sarah Walter (S)
Devon Gessert (D)
Tamie Sather (T)
Gus Jiminez (G)
Danielle Harvey (D)
Matthew Bernstein (M)
Nick Fox (N)
Paul Thompson (P)
Norbert Schuff (N)
Charles DeCArli (C)
Bret Borowski (B)
Jeff Gunter (J)
Matt Senjem (M)
Prashanthi Vemuri (P)
David Jones (D)
Kejal Kantarci (K)
Chad Ward (C)
Robert A Koeppe (RA)
Norm Foster (N)
Eric M Reiman (EM)
Kewei Chen (K)
Chet Mathis (C)
Susan Landau (S)
Nigel J Cairns (NJ)
Erin Householder (E)
Lisa Taylor Reinwald (LT)
Virginia Lee (V)
Magdalena Korecka (M)
Michal Figurski (M)
Karen Crawford (K)
Scott Neu (S)
Tatiana M Foroud (TM)
Steven Potkin (S)
Li Shen (L)
Faber Kelley (F)
Sungeun Kim (S)
Kwangsik Nho (K)
Zaven Kachaturian (Z)
Richard Frank (R)
Peter J Snyder (PJ)
Susan Molchan (S)
Jeffrey Kaye (J)
Joseph Quinn (J)
Betty Lind (B)
Raina Carter (R)
Sara Dolen (S)
Lon S Schneider (LS)
Sonia Pawluczyk (S)
Mauricio Beccera (M)
Liberty Teodoro (L)
Bryan M Spann (BM)
James Brewer (J)
Helen Vanderswag (H)
Adam Fleisher (A)
Judith L Heidebrink (JL)
Joanne L Lord (JL)
Sara S Mason (SS)
Colleen S Albers (CS)
David Knopman (D)
Kris Johnson (K)
Rachelle S Doody (RS)
Javier Villanueva Meyer (JV)
Munir Chowdhury (M)
Susan Rountree (S)
Mimi Dang (M)
Yaakov Stern (Y)
Lawrence S Honig (LS)
Karen L Bell (KL)
Beau Ances (B)
John C Morris (JC)
Maria Carroll (M)
Sue Leon (S)
Mark A Mintun (MA)
Stacy Schneider (S)
Angela Oliver (A)
Randall Griffith (R)
David Clark (D)
David Geldmacher (D)
John Brockington (J)
Erik Roberson (E)
Hillel Grossman (H)
Effie Mitsis (E)
Leyla deToledo-Morrell (L)
Raj C Shah (RC)
Ranjan Duara (R)
Daniel Varon (D)
Maria T Greig (MT)
Peggy Roberts (P)
Marilyn Albert (M)
Chiadi Onyike (C)
Daniel D'Agostino (D)
Stephanie Kielb (S)
James E Galvin (JE)
Dana M Pogorelec (DM)
Brittany Cerbone (B)
Christina A Michel (CA)
Henry Rusinek (H)
Mony J de Leon (MJ)
Lidia Glodzik (L)
Susan De Santi (S)
P Murali Doraiswamy (PM)
Jeffrey R Petrella (JR)
Terence Z Wong (TZ)
Steven E Arnold (SE)
Jason H Karlawish (JH)
David Wolk (D)
Charles D Smith (CD)
Greg Jicha (G)
Peter Hardy (P)
Partha Sinha (P)
Elizabeth Oates (E)
Gary Conrad (G)
Oscar L Lopez (OL)
MaryAnn Oakley (M)
Donna M Simpson (DM)
Anton P Porsteinsson (AP)
Bonnie S Goldstein (BS)
Kim Martin (K)
Kelly M Makino (KM)
M Saleem Ismail (MS)
Connie Brand (C)
Ruth A Mulnard (RA)
Gaby Thai (G)
Catherine McAdams Ortiz (C)
Kyle Womack (K)
Dana Mathews (D)
Mary Quiceno (M)
Ramon Diaz Arrastia (RD)
Richard King (R)
Myron Weiner (M)
Kristen Martin Cook (KM)
Michael DeVous (M)
Allan I Levey (AI)
James J Lah (JJ)
Janet S Cellar (JS)
Jeffrey M Burns (JM)
Heather S Anderson (HS)
Russell H Swerdlow (RH)
Liana Apostolova (L)
Kathleen Tingus (K)
Ellen Woo (E)
Daniel H S Silverman (DHS)
Po H Lu (PH)
George Bartzokis (G)
Neill R Graff Radford (NRG)
Francine Parfitt (F)
Tracy Kendall (T)
Heather Johnson (H)
Martin R Farlow (MR)
Ann Marie Hake (AM)
Brandy R Matthews (BR)
Scott Herring (S)
Cynthia Hunt (C)
Christopher H van Dyck (CH)
Richard E Carson (RE)
Martha G MacAvoy (MG)
Howard Chertkow (H)
Howard Bergman (H)
Chris Hosein (C)
Sandra Black (S)
Bojana Stefanovic (B)
Curtis Caldwell (C)
Ging Yuek Robin Hsiung (GYR)
Howard Feldman (H)
Benita Mudge (B)
Michele Assaly Past (MA)
Andrew Kertesz (A)
John Rogers (J)
Dick Trost (D)
Charles Bernick (C)
Donna Munic (D)
Diana Kerwin (D)
Marek Marsel Mesulam (MM)
Kristine Lipowski (K)
Chuang Kuo Wu (CK)
Nancy Johnson (N)
Carl Sadowsky (C)
Walter Martinez (W)
Teresa Villena (T)
Raymond Scott Turner (RS)
Kathleen Johnson (K)
Brigid Reynolds (B)
Reisa A Sperling (RA)
Keith A Johnson (KA)
Gad Marshall (G)
Meghan Frey (M)
Jerome Yesavage (J)
Joy L Taylor (JL)
Barton Lane (B)
Allyson Rosen (A)
Jared Tinklenberg (J)
Marwan N Sabbagh (MN)
Christine M Belden (CM)
Sandra A Jacobson (SA)
Sherye A Sirrel (SA)
Neil Kowall (N)
Ronald Killiany (R)
Andrew E Budson (AE)
Alexander Norbash (A)
Patricia Lynn Johnson (PL)
Thomas O Obisesan (TO)
Saba Wolday (S)
Joanne Allard (J)
Alan Lerner (A)
Paula Ogrocki (P)
Leon Hudson (L)
Evan Fletcher (E)
Owen Carmichael (O)
John Olichney (J)
Charles DeCarli (C)
Smita Kittur (S)
Michael Borrie (M)
T Y Lee (TY)
Rob Bartha (R)
Sterling Johnson (S)
Sanjay Asthana (S)
Cynthia M Carlsson (CM)
Steven G Potkin (SG)
Adrian Preda (A)
Dana Nguyen (D)
Pierre Tariot (P)
Stephanie Reeder (S)
Vernice Bates (V)
Horacio Capote (H)
Michelle Rainka (M)
Douglas W Scharre (DW)
Maria Kataki (M)
Anahita Adeli (A)
Earl A Zimmerman (EA)
Dzintra Celmins (D)
Alice D Brown (AD)
Godfrey D Pearlson (GD)
Karen Blank (K)
Karen Anderson (K)
Robert B Santulli (RB)
Tamar J Kitzmiller (TJ)
Eben S Schwartz (ES)
Kaycee M Sink (KM)
Jeff D Williamson (JD)
Pradeep Garg (P)
Franklin Watkins (F)
Brian R Ott (BR)
Henry Querfurth (H)
Geoffrey Tremont (G)
Stephen Salloway (S)
Paul Malloy (P)
Stephen Correia (S)
Howard J Rosen (HJ)
Bruce L Miller (BL)
Jacobo Mintzer (J)
Kenneth Spicer (K)
David Bachman (D)
Elizabether Finger (E)
Stephen Pasternak (S)
Irina Rachinsky (I)
Dick Drost (D)
Nunzio Pomara (N)
Raymundo Hernando (R)
Antero Sarrael (A)
Susan K Schultz (SK)
Laura L Boles Ponto (LLB)
Hyungsub Shim (H)
Karen Elizabeth Smith (KE)
Norman Relkin (N)
Gloria Chaing (G)
Lisa Raudin (L)
Amanda Smith (A)
Kristin Fargher (K)
Balebail Ashok Raj (BA)

Références

Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J. & Langa, K. M. Monetary costs of dementia in the United States. N. Engl. J. Med. 368, 1326–1334 (2013).
pubmed: 23550670 pmcid: 3959992
Alafuzoff, I. et al. Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 18, 484–496 (2008).
pubmed: 18371174 pmcid: 2659377
Hyman, B. T. et al. National Institute on Aging—Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 8, 1–13 (2012).
pubmed: 22265587 pmcid: 3266529
Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).
pubmed: 12130773
Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207–216 (2013).
pubmed: 23332364 pmcid: 3622225
La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, eaau5732 (2020).
pubmed: 31894103 pmcid: 7035952
Bejanin, A. et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain 140, 3286–3300 (2017).
pubmed: 29053874 pmcid: 5841139
Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).
pubmed: 1759558
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389–404 (2006).
pubmed: 16906426 pmcid: 3906709
Schöll, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971–982 (2016).
pubmed: 26938442 pmcid: 4779187
Schwarz, A. Regional profiles of the candidate tau PET ligand
pubmed: 26936940
Murray, M. E. et al. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785–796 (2011).
pubmed: 21802369 pmcid: 3175379
Whitwell, J. L. et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer’s disease: a case-control study. Lancet Neurol. 11, 868–877 (2012).
pubmed: 22951070 pmcid: 3490201
Ferreira, D., Nordberg, A. & Westman, E. Biological subtypes of Alzheimer’s disease: a systematic review and meta-analysis. Neurology 94, 436–448 (2020).
pubmed: 32047067 pmcid: 7238917
Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain 139, 1551–1567 (2016).
pubmed: 26962052 pmcid: 5006248
Crutch, S. J. et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 13, 870–884 (2017).
pubmed: 28259709 pmcid: 5788455
Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014 (2011).
pubmed: 21325651 pmcid: 3059138
Ossenkoppele, R. et al. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain 138, 2732–2749 (2015).
pubmed: 26141491 pmcid: 4623840
Drummond, E. et al. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease. Acta Neuropathol. 133, 933–954 (2017).
pubmed: 28258398 pmcid: 5503748
Crist, A. M. et al. Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5. Preprint at bioRxiv https://doi.org/10.1101/2020.12.18.423469 (2020).
Risacher, S. L. et al. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology 89, 2176–2186 (2017).
pubmed: 29070667 pmcid: 5696639
Ossenkoppele, R. et al. Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer’s disease. Alzheimers Dement. 16, 335–344 (2020).
pubmed: 31672482 pmcid: 7012375
Young, A. L. et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat. Commun. 9, 4273 (2018).
pubmed: 30323170 pmcid: 6189176
Dong, A. et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers. Brain 140, 735–747 (2017).
pubmed: 28003242
Noh, Y. et al. Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology 83, 1936–1944 (2014).
pubmed: 25344382 pmcid: 4248459
Tam, A. et al. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer’s dementia. Gigascience 8, giz055 (2019).
pubmed: 31077314 pmcid: 6511068
Vogel, J. W. et al. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer’s disease. Hum. Brain Mapp. 40, 638–651 (2019).
pubmed: 30368979
Leuzy, A. et al. Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders. JAMA Neurol. 77, 955–965 (2020).
pubmed: 32391858
Vogel, J. W. et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nat. Commun. 11, 2612 (2020).
pubmed: 32457389 pmcid: 7251068
Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V. & Cummings, J. L. Early-onset Alzheimer’s disease is associated with greater pathologic burden. J. Geriatr. Psychiatry Neurol. 20, 29–33 (2007).
pubmed: 17341768
Whitwell, J. L. et al. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer’s disease. Alzheimers Dement. 15, 675–685 (2019).
pubmed: 30853465 pmcid: 6511453
Pontecorvo, M. J. et al. A multicentre longitudinal study of flortaucipir (
pubmed: 31009046 pmcid: 6536847
Jack, C. R. et al. Predicting future rates of tau accumulation on PET. Brain 143, 3136–3150 (2020).
pubmed: 33094327 pmcid: 7586089
La Joie, R. et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology 96, e650–e661 (2021).
pubmed: 33262228 pmcid: 7884991
Dujardin, S. et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease. Nat. Med. 26, 1256–1263 (2020).
pubmed: 32572268 pmcid: 7603860
Aoyagi, A. et al. Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain. Sci. Transl. Med. 11, eaat8462 (2019).
pubmed: 31043574 pmcid: 6640844
Koedam, E. L. G. E. et al. Early-versus late-onset Alzheimer’s disease: more than age alone. J. Alzheimers Dis. 19, 1401–1408 (2010).
pubmed: 20061618
Sun, N., Mormino, E. C., Chen, J., Sabuncu, M. R. & Yeo, B. T. T. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer’s disease. Neuroimage 201, 116043 (2019).
pubmed: 31344486
Franzmeier, N. et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease. Sci. Adv. 6, eabd1327 (2020).
pubmed: 33246962 pmcid: 7695466
Mukaetova-Ladinska, E. B. et al. Regional distribution of paired helical filaments and normal tau proteins in aging and in Alzheimer’s disease with and without occipital lobe involvement. Dement. Geriatr. Cogn. Disord. 3, 61–69 (1992).
McKee, A. C. et al. Visual association pathology in preclinical Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 621–630 (2006).
pubmed: 16783172
Pikkarainen, M., Kauppinen, T. & Alafuzoff, I. Hyperphosphorylated tau in the occipital cortex in aged nondemented subjects. J. Neuropathol. Exp. Neurol. 68, 653–660 (2009).
pubmed: 19458543
Hanna Al-Shaikh, F. S. et al. Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease. JAMA Neurol. 77, 225–233 (2019).
pmcid: 6820048
Machado, A. et al. The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study. Alzheimers Res. Ther. 12, 51 (2020).
pubmed: 32375872 pmcid: 7203806
Rogalski, E., Johnson, N., Weintraub, S. & Mesulam, M. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch. Neurol. 65, 244–248 (2008).
pubmed: 18268195 pmcid: 2892116
Ossenkoppele, R. et al. Discriminative accuracy of [
pubmed: 30326496 pmcid: 6233630
Miller, Z. A. Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia. Brain Commun. 1, fcz027 (2019).
pubmed: 32699834 pmcid: 7364264
Hyman, B. T. Tau propagation, different tau phenotypes, and prion-like properties of tau. Neuron 82, 1189–1190 (2014).
pubmed: 24945760
He, Z. et al. Transmission of tauopathy strains is independent of their isoform composition. Nat. Commun. 11, 7 (2020).
pubmed: 31911587 pmcid: 6946697
Leng, K. et al. Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease. Nat. Neurosci. 24, 276–287 (2021).
pubmed: 33432193 pmcid: 7854528
Lemoine, L., Leuzy, A., Chiotis, K., Rodriguez-Vieitez, E. & Nordberg, A. Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimers Dement. (Amst.) 10, 232–236 (2018).
Baker, S. L., Harrison, T. M., Maaß, A., La Joie, R. & Jagust, W. Effect of off-target binding on 18 F-flortaucipir variability in healthy controls across the lifespan. J. Nucl. Med. https://doi.org/10.2967/jnumed.118.224113 (2019).
Smith, R. et al. Head-to-head comparison of tau positron emission tomography tracers [
pubmed: 31612245
Fleisher, A. S. et al. Positron emission tomography imaging with [
pubmed: 32338734
Lowe, V. J. et al. Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement. 16, 561–571 (2020).
pubmed: 31784374 pmcid: 7067654
Soleimani-Meigooni, D. N. et al.
pubmed: 33141172 pmcid: 7719031
Smith, R., Wibom, M., Pawlik, D., Englund, E. & Hansson, O. Correlation of in vivo [
pubmed: 30508025
Cho, H. et al. Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum. Neurobiol. Aging 68, 76–84 (2018).
pubmed: 29751288
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J. & Evans, A. C. Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders. PLoS Comput. Biol. 10, e1003956 (2014).
pubmed: 25412207 pmcid: 4238950
Craddock, C. et al. Towards automated analysis of connectomes: the configurable pipeline for the analysis of connectomes (C-PAC). Front. Neuroinform. https://doi.org/10.3389/conf.fninf.2014.08.00117 (2013).
doi: 10.3389/conf.fninf.2014.08.00117

Auteurs

Jacob W Vogel (JW)

Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada. jacob.vogel@mail.mcgill.ca.

Alexandra L Young (AL)

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Neil P Oxtoby (NP)

Centre for Medical Image Computing, University College London, London, UK.
Department of Computer Science, University College London, London, UK.

Ruben Smith (R)

Clinical Memory Research Unit, Lund University, Lund, Sweden.
Department of Neurology, Skåne University Hospital, Lund, Sweden.

Rik Ossenkoppele (R)

Clinical Memory Research Unit, Lund University, Lund, Sweden.
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Olof T Strandberg (OT)

Clinical Memory Research Unit, Lund University, Lund, Sweden.

Renaud La Joie (R)

Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Leon M Aksman (LM)

Centre for Medical Image Computing, University College London, London, UK.
Department of Medical Physics and Biomedical Engineering, University College London, London, UK.

Michel J Grothe (MJ)

Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain.

Yasser Iturria-Medina (Y)

Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Michael J Pontecorvo (MJ)

AVID Radiopharmaceuticals, Philadelphia, PA, USA.

Michael D Devous (MD)

AVID Radiopharmaceuticals, Philadelphia, PA, USA.

Gil D Rabinovici (GD)

Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.

Daniel C Alexander (DC)

Centre for Medical Image Computing, University College London, London, UK.
Department of Computer Science, University College London, London, UK.

Chul Hyoung Lyoo (CH)

Departments of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Alan C Evans (AC)

Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Oskar Hansson (O)

Clinical Memory Research Unit, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.
Memory Clinic, Skåne University Hospital, Malmö, Sweden. oskar.hansson@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH